Project: Addiction, Health Risks and Recovery in Context of Social Precarity: How to Better Address Complex Needs Taking into Account Gender and Life Stages

Acronym	GENDER-ARP (Reference Number: GNP-72)
Project Topic	Numerous studies show the need to design interventions for psychoactive substances (PS) users not only from a biomedical angle, but also to act upon the different types of vulnerabilities they face. The general aim of this transnational Canadian, French and Belgian study is to better understand how gender and life stages influence addiction, health risks, and recovery trajectories in order to guide the development of integrated services that address complex social and health care needs. The three specific objectives of the project take into account gender and life stages issues in order to: 1) identify specific vulnerabilities and capacities in people with SUD who experience social precarity over a lifelong trajectory of PS use and related risk behaviors; 2) understand long-term service and recovery trajectories related to PS use and health risks within this population; and 3) guide the development of long-term integrated services that better address the complex social and health needs of this population. We propose to combine the following methods: semi-structured interviews on PS use, health-risk and recovery trajectories; a systematic literature review about best practices for gender-responsive addiction and harm reduction long-term integrated services; and consensus development conferences with expert panels. This transnational study will develop contextualized knowledge that can enhance gender-responsive services taking into account life stages, locally and internationally, adapted to the complex care and social needs of specific vulnerable populations.
Website	visit project website
Network	GENDER NET Plus
Call	1st Joint Call on Gender and UN Sustainable Development Goals

Project partner

Number	Name	Role	Country
1	Université de Sherbrooke	Coordinator	Canada
2	French National Institute for Health and Medical Research	Partner	France
3	University of Liege	Partner	Belgium